image description

Tag: Stacie Bell

Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics

NEW YORK, N.Y. — [March 14, 2024]: Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on a Phase 1 trial of the company novel NK cell-based therapy AlloNK® (also known as AB-101), in combination with anti-CD20 antibodies, for patients with active lupus nephritis – inflammation […] Read More

Lupus Research Alliance Appoints New Executive Vice President of Clinical Research Affiliate Lupus Therapeutics

NEW YORK, NY. January 17, 2023— The Lupus Research Alliance (LRA) announced the appointment of Stacie J. Bell, PhD as Executive Vice President to lead the organization’s clinical research affiliate Lupus Therapeutics (LT). Dr. Bell comes to Lupus Therapeutics with 25+ years of experience in discovery research, clinical development, and patient engagement in the biopharmaceutical […] Read More